- Cost-effectiveness analysis of serplulimab plus chemotherapy in the first-line treatment for PD-L1-positive esophageal squamous cell carcinoma in China
- 点击次数:
- 所属单位:公共卫生学院
- 发表刊物:Frontiers in Immunology
- 论文编号:AACF629AB0EF4A22870C33F9DE38ECDF
- 卷号:14
- 字数:7
- 是否译文:否
- 发表时间:2023-05-04